Skip to main content
Top
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility

Authors: Zihan Sun, Jing Pei, Fengyun Cui, Yanhua Jing, Chengjin Hu

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

The relationship of non-Hodgkin’s lymphoma (NHL) with the presence of interleukin-4 genetic polymorphism -588C>T has been reported with inconsistent results. The objective of this study was to quantitatively evaluate the association between -588C>T polymorphism and NHL susceptibility. Two investigators independently searched Medline and the Cochrane Library up to September 20, 2013. Pooled odds ratio and 95 % confidence interval were calculated using a fixed or random effects model. Statistical analysis was performed with Review Manage 5.0 and Stata 11. Of the six case-control studies selected for this meta-analysis, a total of 1,909 NHL cases and 1,834 controls were included. The combined results based on all studies suggested that -588C>T was not associated with NHL risk under all genetic models. When stratifying for race, no noteworthy associations were observed in mixed populations or Caucasians. This meta-analysis suggests that IL-4 -588C>T polymorphism might not be a risk factor for NHL risk. However, further well-designed studies are required to confirm our findings.
Literature
1.
go back to reference Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol. 2002;29:258–63.CrossRefPubMed Rosenwald A, Staudt LM. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin Oncol. 2002;29:258–63.CrossRefPubMed
2.
go back to reference Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP, Wang LY, et al. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res. 2012;31:27.CrossRefPubMedPubMedCentral Gao SM, Yang JJ, Chen CQ, Chen JJ, Ye LP, Wang LY, et al. Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells. J Exp Clin Cancer Res. 2012;31:27.CrossRefPubMedPubMedCentral
3.
go back to reference Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–97.CrossRefPubMed Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283–97.CrossRefPubMed
4.
go back to reference Wen-Li Z, Jian W, Yan-Fang T, Xing F, Yan-Hong L, Xue-Ming Z, et al. Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines. J Exp Clin Cancer Res. 2012;31:92.CrossRefPubMedPubMedCentral Wen-Li Z, Jian W, Yan-Fang T, Xing F, Yan-Hong L, Xue-Ming Z, et al. Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines. J Exp Clin Cancer Res. 2012;31:92.CrossRefPubMedPubMedCentral
5.
go back to reference Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, et al. Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res. 2012;31:48.CrossRefPubMedPubMedCentral Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, et al. Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res. 2012;31:48.CrossRefPubMedPubMedCentral
6.
go back to reference Zhang H, Xu Y, Zhang Z, Liu R, Ma B. Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol. 2012;13:14.CrossRefPubMedPubMedCentral Zhang H, Xu Y, Zhang Z, Liu R, Ma B. Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC Immunol. 2012;13:14.CrossRefPubMedPubMedCentral
7.
go back to reference Zhang HT, Xu Y, Zhang ZH, Li L. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer. Genet Mol Res. 2012;11(2):1642–50.CrossRefPubMed Zhang HT, Xu Y, Zhang ZH, Li L. Meta-analysis of epidemiological studies demonstrates significant association of PTGS2 polymorphism rs689470 and no significant association of rs20417 with prostate cancer. Genet Mol Res. 2012;11(2):1642–50.CrossRefPubMed
10.
go back to reference Zhang H, Ma H, Li L, Zhang Z, Xu Y. Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis. PLoS One. 2013;8:e69366.CrossRefPubMedPubMedCentral Zhang H, Ma H, Li L, Zhang Z, Xu Y. Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis. PLoS One. 2013;8:e69366.CrossRefPubMedPubMedCentral
12.
go back to reference Serefoglou Z, Yapijakis C, Nkenke E, Vairaktaris E. Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol. 2008;44:1093–9.CrossRefPubMed Serefoglou Z, Yapijakis C, Nkenke E, Vairaktaris E. Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol. 2008;44:1093–9.CrossRefPubMed
13.
go back to reference Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy. 1995;25:74–8.CrossRefPubMed Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy. 1995;25:74–8.CrossRefPubMed
14.
go back to reference Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002;3:107–9.CrossRefPubMed Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun. 2002;3:107–9.CrossRefPubMed
15.
go back to reference Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Line SR. Frequencies of the -330 (T/G) IL-2 and -590(T/C) IL-4 gene polymorphisms in a population from southeastern Brazil. Eur J Immunogenet. 2002;9:293–6.CrossRef Scarel-Caminaga RM, Trevilatto PC, Souza AP, Brito RB, Line SR. Frequencies of the -330 (T/G) IL-2 and -590(T/C) IL-4 gene polymorphisms in a population from southeastern Brazil. Eur J Immunogenet. 2002;9:293–6.CrossRef
16.
go back to reference Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int. 2005;26:48–51.CrossRefPubMed Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int. 2005;26:48–51.CrossRefPubMed
17.
go back to reference Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.CrossRefPubMed Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.CrossRefPubMed
18.
go back to reference Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, et al. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. AIDS. 2010;24:1025–33.CrossRefPubMedPubMedCentral Wong HL, Breen EC, Pfeiffer RM, Aissani B, Martinson JJ, Margolick JB, et al. Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study. AIDS. 2010;24:1025–33.CrossRefPubMedPubMedCentral
19.
go back to reference Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.CrossRefPubMed Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.CrossRefPubMed
20.
go back to reference Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.CrossRefPubMedPubMedCentral Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.CrossRefPubMedPubMedCentral
22.
go back to reference Zhang H, Qi C, Wang A, Li L, Xu Y. High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer. Tumor Biol. 2013. doi:10.1007/s13277-013-1268-z. Zhang H, Qi C, Wang A, Li L, Xu Y. High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer. Tumor Biol. 2013. doi:10.​1007/​s13277-013-1268-z.
23.
go back to reference Zhang H, Qi C, Wang A, Yao B, Li L, Wang Y, et al. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer. J Exp Clin Cancer Res. 2013;32:77.CrossRefPubMedPubMedCentral Zhang H, Qi C, Wang A, Yao B, Li L, Wang Y, et al. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer. J Exp Clin Cancer Res. 2013;32:77.CrossRefPubMedPubMedCentral
24.
go back to reference Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH, Yu FJ. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. J Exp Clin Cancer Res. 2011;30:110.CrossRefPubMedPubMedCentral Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH, Yu FJ. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level. J Exp Clin Cancer Res. 2011;30:110.CrossRefPubMedPubMedCentral
25.
go back to reference Mhaidat NM, Alshogran OY, Khabour OF, Alzoubi KH, Matalka II, Haddadin WJ, et al. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin’s Lymphoma. J Exp Clin Cancer Res. 2011;30:68.CrossRefPubMedPubMedCentral Mhaidat NM, Alshogran OY, Khabour OF, Alzoubi KH, Matalka II, Haddadin WJ, et al. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin’s Lymphoma. J Exp Clin Cancer Res. 2011;30:68.CrossRefPubMedPubMedCentral
26.
go back to reference Kowalska M, Tajer J, Chechlinska M, Fuksiewicz M, Kotowicz B, Syczewska M, et al. Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biol. 2012;33(5):1733–8.CrossRef Kowalska M, Tajer J, Chechlinska M, Fuksiewicz M, Kotowicz B, Syczewska M, et al. Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biol. 2012;33(5):1733–8.CrossRef
27.
go back to reference Yang J, Wang S, Zhao G, Sun B. Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study. J Exp Clin Cancer Res. 2011;30:51.CrossRefPubMedPubMedCentral Yang J, Wang S, Zhao G, Sun B. Effect of chemokine receptors CCR7 on disseminated behavior of human T cell lymphoma: clinical and experimental study. J Exp Clin Cancer Res. 2011;30:51.CrossRefPubMedPubMedCentral
28.
go back to reference Pei JH, Luo SQ, Zhong Y, Chen JH, Xiao HW, Hu WX. The association between non-Hodgkin lymphoma and methylation of p73. Tumor Biol. 2011;32(6):1133–8.CrossRef Pei JH, Luo SQ, Zhong Y, Chen JH, Xiao HW, Hu WX. The association between non-Hodgkin lymphoma and methylation of p73. Tumor Biol. 2011;32(6):1133–8.CrossRef
29.
go back to reference Diggs DL, Harris KL, Rekhadevi PV, Ramesh A. Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer. Tumor Biol. 2012;33(4):1255–60.CrossRef Diggs DL, Harris KL, Rekhadevi PV, Ramesh A. Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in ApcMin mouse model of colon cancer. Tumor Biol. 2012;33(4):1255–60.CrossRef
Metadata
Title
Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility
Authors
Zihan Sun
Jing Pei
Fengyun Cui
Yanhua Jing
Chengjin Hu
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1642-5

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine